Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor.
The degree of alkylation of haemoglobin was determined at different times after treatment of mice with one directly active alkylating agent, ethylene oxide, and one agent that requires metabolic activation, dimethylnitrosamine. Because of the random alkylation of red blood cells of various ages and the stability of alkylated haemoglobin, the amount of alkylated amino acids in haemoglobin decreases linearly with time, reaching the value zero after about 40 days, the life-span of erythrocytes in the mouse. This provides a basis for the use of haemoglobin as a monitor for integral doses of genotoxic environmental chemicals.
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D004247:DNA / Q000378:metabolism; D004128:Dimethylnitrosamine / Q000494:pharmacology*; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000378:metabolism; D005027:Ethylene Oxide / Q000494:pharmacology*; D006454:Hemoglobins / Q000378:metabolism*; D051379:Mice; D009154:Mutation; D009602:Nitrosamines / Q000494:pharmacology*; D013154:Spleen / Q000378:metabolism
D000477:Alkylating Agents; D006454:Hemoglobins; D009602:Nitrosamines; D004247:DNA; D005027:Ethylene Oxide; D004128:Dimethylnitrosamine